Nautilus Biotechnology (NAUT) Competitors $0.82 +0.04 (+4.98%) As of 07/3/2025 02:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAUT vs. QTRX, SENS, MASS, FEIM, KEQU, RPID, OWLT, SEER, ODYS, and PREShould you be buying Nautilus Biotechnology stock or one of its competitors? The main competitors of Nautilus Biotechnology include Quanterix (QTRX), Senseonics (SENS), 908 Devices (MASS), Frequency Electronics (FEIM), Kewaunee Scientific (KEQU), Rapid Micro Biosystems (RPID), Owlet (OWLT), Seer (SEER), Odysight.ai (ODYS), and Prenetics Global (PRE). These companies are all part of the "measuring and control equipment" industry. Nautilus Biotechnology vs. Its Competitors Quanterix Senseonics 908 Devices Frequency Electronics Kewaunee Scientific Rapid Micro Biosystems Owlet Seer Odysight.ai Prenetics Global Nautilus Biotechnology (NASDAQ:NAUT) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment. Does the media refer more to NAUT or QTRX? In the previous week, Nautilus Biotechnology had 1 more articles in the media than Quanterix. MarketBeat recorded 1 mentions for Nautilus Biotechnology and 0 mentions for Quanterix. Nautilus Biotechnology's average media sentiment score of 0.90 beat Quanterix's score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the media. Company Overall Sentiment Nautilus Biotechnology Positive Quanterix Neutral Is NAUT or QTRX more profitable? Nautilus Biotechnology has a net margin of 0.00% compared to Quanterix's net margin of -36.82%. Quanterix's return on equity of -15.07% beat Nautilus Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Nautilus BiotechnologyN/A -31.87% -27.39% Quanterix -36.82%-15.07%-12.26% Do analysts prefer NAUT or QTRX? Nautilus Biotechnology currently has a consensus target price of $2.13, suggesting a potential upside of 158.52%. Quanterix has a consensus target price of $15.60, suggesting a potential upside of 126.91%. Given Nautilus Biotechnology's higher probable upside, research analysts clearly believe Nautilus Biotechnology is more favorable than Quanterix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Quanterix 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders hold more shares of NAUT or QTRX? 50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by insiders. Comparatively, 6.9% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, NAUT or QTRX? Nautilus Biotechnology has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Which has preferable earnings & valuation, NAUT or QTRX? Quanterix has higher revenue and earnings than Nautilus Biotechnology. Quanterix is trading at a lower price-to-earnings ratio than Nautilus Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNautilus BiotechnologyN/AN/A-$70.78M-$0.54-1.52Quanterix$137.42M2.50-$38.53M-$1.30-5.29 SummaryNautilus Biotechnology beats Quanterix on 8 of the 15 factors compared between the two stocks. Get Nautilus Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAUT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAUT vs. The Competition Export to ExcelMetricNautilus BiotechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$103.44M$2.91B$5.54B$9.05BDividend YieldN/A2.44%5.24%4.02%P/E Ratio-1.5221.5627.4320.23Price / SalesN/A281.76422.11118.64Price / CashN/A42.7336.8958.07Price / Book0.507.518.045.67Net Income-$70.78M-$55.05M$3.18B$249.13M7 Day Performance18.50%4.61%2.89%3.28%1 Month Performance11.08%4.72%3.70%5.56%1 Year Performance-64.26%5.92%36.15%21.12% Nautilus Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAUTNautilus Biotechnology2.3078 of 5 stars$0.82+5.0%$2.13+158.5%-63.8%$103.44MN/A-1.52130QTRXQuanterix2.1045 of 5 stars$6.65flat$15.60+134.6%-45.1%$332.20M$137.42M-5.12460SENSSenseonics1.5712 of 5 stars$0.48-3.6%$1.55+225.4%+27.6%$311.67M$23.68M-3.6690News CoverageMASS908 Devices1.5739 of 5 stars$7.13+5.9%$5.33-25.2%+36.4%$241.35M$59.63M-13.2060Gap DownFEIMFrequency Electronics2.4992 of 5 stars$22.71-2.4%N/A+144.1%$225.27M$55.27M9.42200High Trading VolumeKEQUKewaunee Scientific2.1817 of 5 stars$58.70+3.6%N/A+26.6%$161.76M$240.47M15.331,006News CoveragePositive NewsAnalyst UpgradeRPIDRapid Micro Biosystems1.4979 of 5 stars$3.45-3.6%$8.00+131.9%+513.6%$156.92M$28.05M-3.35200News CoveragePositive NewsOWLTOwlet0.8047 of 5 stars$8.39+6.2%$7.75-7.6%+112.2%$130.54M$78.10M-5.87106High Trading VolumeSEERSeer2.1382 of 5 stars$2.14+0.9%$3.00+40.2%+36.6%$124.80M$14.17M-1.52160News CoverageODYSOdysight.ai1.2379 of 5 stars$5.10-27.2%$10.00+96.1%N/A$114.38M$5.84M-5.0040News CoverageHigh Trading VolumePREPrenetics Global1.6654 of 5 stars$8.52+0.4%$9.00+5.6%+37.9%$103.62M$30.62M-2.141Analyst UpgradeHigh Trading Volume Related Companies and Tools Related Companies QTRX Competitors SENS Competitors MASS Competitors FEIM Competitors KEQU Competitors RPID Competitors OWLT Competitors SEER Competitors ODYS Competitors PRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAUT) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
